An apparatus for the uninterrupted administration of fluid to an animal body during clean blood collections is disclosed. Embodiments include an intravenous device defining a first fluid channel, wherein the first fluid channel is configured to selectively transport IV fluid to an animal body and draw a bodily fluid from the body, and a connection member configured to connect to a catheter to the first fluid channel and defining a concave distal end. A second fluid channel continuously provides IV fluid to a lumen coaxially located within the catheter. The concave surface is shaped to create a fluid flow pattern that quickly and completely removes residual bodily fluid remaining at the concave distal end. Embodiments include a concave surface defining an asymmetric funnel shape, a vertex of which is centered on the first fluid channel.

A cannula tubing having a series of apertures at its distal end, so that the end of the tube is not the only egress point for the payload of the cannula. The cannula tubing is affixed to a base, which is configured to accept an input connector on the end opposing the cannula. The base is configured so that input medication from the connector flows down the cannula. The base is affixed to the patient via adhesive. The perforated cannula distributes the dose of the medication across a wider area. This has been demonstrated to increase uptake rate of some medications (reducing the time to peak absorption rate). Administering medication (such as insulin) over a greater area may lessen unwanted side effects of subcutaneous injecting, such as lipohypertrophy, scarring, or localized drug resistance.

A medical device configured to restrict medicament dispersion within a cerebrospinal fluid flow of the patient. The medical device including an implantable catheter having a distal end configured to be positioned within a flow of the cerebrospinal fluid, a proximal end, a body defining a lumen extending lengthwise along the implantable catheter configured to enable a flow of medicament from the proximal end to an infusion port located in proximity to the distal end, and a contoured surface defined by an exterior of the body in proximity to the infusion port configured to inhibit dispersion of the medicament within the cerebrospinal fluid.

A multi-catheter infusion system and method for the localized delivery of medications while minimally affecting patient mobility for an extended period of time. The multi-catheter infusion system includes a cannula and a plurality of catheters. The cannula includes a first end for connecting to a drug delivery system and a second end for connecting to the plurality of catheters. The plurality of catheters are in fluid communication with the cannula for delivering a drug to a target area of a patient. Each catheter includes a multi-orifice distal end.

The invention relates to an implantable access device for accessing the vascular system of a human or animal body, particularly subcutaneously implantable access port, comprising: at least one inlet opening, at least one outlet opening and at least one passageway between the at least one inlet opening and the at least one outlet opening, further comprising at least one valve assembly in the at least one passageway, which in a first, unactuated operating condition prevents a fluid flow through the at least one passageway and in a second, actuated operating condition permits a fluid flow through the at least one passageway, which is characterized in that the at least one valve assembly in the first, unactuated operating condition is longitudinally elongated and radially compressed in such a way to prevent a fluid flow through the at least one passageway and that the at least one valve assembly in the second, actuated operating condition is longitudinally compressed and radially elongated in such a way to permit a fluid flow through the at least one passageway.

A feeding tube aperture supported and aligned with a feeding tube opening in an abdominal wall of a patient, including a base having a first end surface transverse to an axis of the base and a feeding tube, a second opposed end surface, a central feeding tube passage extending between the first and second end surfaces, a plurality of vent passages around the feeding tube passage and extending between the first and second end surfaces, a hollow, cylindrical feeding tube support extension centered on and extending outwardly from the feeding tube passage to support and align the feeding tube aperture, and a plurality of spaced apart resilient spacers extending outwards from the second end surface. The plurality of spaced apart resilient spacers resiliently space the second end surface from the abdominal wall and form a plurality of air passages to allow a flow of air around the abdominal wall and the feeding tube opening.

A surgical access assembly and method of use is disclosed. The surgical access assembly comprises an outer sheath and an obturator. The outer sheath and obturator are configured to be delivered to an area of interest within the brain. Either the outer sheath or the obturator may be configured to operate with a navigational system to track the location of either within the brain. Once positioned at a desired location, the obturator is removed, leaving a distal end of the outer sheath adjacent an area of interest, and creating a working corridor. Interrogation of the area of interest may be performed to evaluate a disorder and/or abnormality, as well as evaluate treatment regimes. Interventional devices may also be introduced to the area of interest, as well as a variety of treatments.

The present disclosure relates to implantable encapsulation devices for housing a biological moiety or a therapeutic device that contains a biological moiety. Particularly, aspects of the present disclosure are directed to an implantable apparatus that includes a distal end, a proximal end, a manifold including at least one access port positioned either at the distal end or the proximal end, and a plurality of containment tubes affixed to the manifold and in fluid communication with the at least one access port. Additionally, the encapsulation device may contain a flush port and a tube that are fluidly connected to the manifold. The containment tubes may contain therein a biological moiety (e.g., cells) or a therapeutic device (e.g. a cell encapsulation member).

A lubrication device for lubricating a joint of a human or mammal patient, which is entirely implantable in a patient's body, comprises a reservoir for storing a lubricating fluid and a fluid connection for introducing the lubricating fluid into the joint when the device is implanted in the patient's body. Further, the fluid connection comprises a fluid connection device connecting the reservoir with the joint such that a lubricating fluid flow is established from the reservoir into the joint. The fluid connection comprises either an infusion needle adapted to be intermittently placed into the joint for injecting the lubricating fluid, or a tube adapted to be permanently placed into the joint for continuously injecting the lubricating fluid.

Devices and methods for retrieving percutaneously implanted catheter systems such as a heart valve repair system. The devices include at least one locking connector at the distal end of a flexible elongated extension for coupling to an implanted tubular member. The locking connector may be a tubular anchor having a pair of distal prongs which are biased outward and face in a proximal direction, as well as an expandable auxetic midsection. Inserting the tubular anchor into the implanted tubular member flexes the distal prongs inward such that they prevent proximal movement of the tubular anchor. A user pulls on the proximal end of the tubular anchor to expand the auxetic midsection and lock the two pieces together. The devices and methods are particularly useful to attach extensions to implanted concentric tubes to enable relative axial force application.